J. P. Dubey and J. L. Jones, Toxoplasma gondii infection in humans and animals in the United States, Int J Parasitol, vol.38, pp.1257-1278, 2008.

A. M. Tenter, A. R. Heckeroth, and L. M. Weiss, Toxoplasma gondii: from animals to humans, Int J Parasitol, vol.30, pp.124-131, 2000.

L. Phan, K. Kasza, J. Jalbrzikowski, A. G. Noble, P. Latkany et al., Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life, Am J Ophthalmol, vol.146, pp.375-384, 2008.

R. Mcleod, K. M. Boyer, D. Lee, E. Mui, K. Wroblewski et al., Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, Clin Infect Dis, vol.54, pp.1595-1605, 2012.

M. Wallon, F. Peyron, C. Cornu, S. Vinault, M. Abrahamowicz et al., Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years, Clin Infect Dis, vol.56, pp.1223-1231, 2013.

M. Wallon, J. G. Garweg, M. Abrahamowicz, C. Cornu, S. Vinault et al., Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence, Pediatrics, vol.133, pp.601-608, 2014.

R. Thiebaut, S. Leproust, G. Chene, and R. Gilbert, Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data, Lancet, vol.369, pp.115-122, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00143965

A. R. Prusa, D. C. Kasper, A. Pollak, A. Gleiss, T. Waldhoer et al., The Austrian Toxoplasmosis Register, Clin Infect Dis, vol.60, pp.4-10, 1992.

D. Roser, H. V. Nielsen, E. Petersen, P. Saugmann-jensen, and B. Norgaard-pedersen, Congenital toxoplasmosis-a report on the Danish neonatal screening programme 1999-2007, J Inherit Metab Dis, vol.33, pp.241-247, 2010.

J. E. Gomez-marin, M. T. Montoya-de-londono, and J. C. Castano-osorio, A maternal screening program for congenital toxoplasmosis in Quindio, Colombia and application of mathematical models to estimate incidences using age-stratified data, Am J Trop Med Hyg, vol.57, pp.180-186, 1997.

T. Tan-torres-edejer, R. Baltussen, T. Adam, R. Hutubessy, A. Acharya et al., Making choices in health: WHO guide to cost-effectiveness analysis, 2003.

H. Autorité-de-santé, Choix mé thodologiques pour l'é valuation économique à la HAS, vol.83, 2011.

F. Peyron, L. 'ollivier, C. Mandelbrot, L. Wallon, M. Piarroux et al., Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02070252

G. Pappas, N. Roussos, and M. E. Falagas, Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis, Int J Parasitol, vol.39, pp.1385-1394, 2009.

M. Tourdjman, C. Tché, H. De-valk, V. Goulet, L. Strat et al., Toxoplasmose chez les femmes enceintes en France: é volution de la sé ropré valence et des facteurs associé s entre 1995 et 2010, à partir des Enquêtes nationales périnatales, pp.264-272, 2015.

J. L. Jones, D. Kruszon-moran, K. Sanders-lewis, and M. Wilson, Toxoplasma gondii infection in the United States, Am J Trop Med Hyg, vol.77, pp.405-410, 1999.

K. Petersson, B. Stray-pedersen, G. Malm, M. Forsgren, and B. Evengard, Seroprevalence of Toxoplasma gondii among pregnant women in Sweden, Acta Obstet Gynecol Scand, vol.79, pp.824-829, 2000.

F. Nogareda, L. Strat, Y. Villena, I. , D. Valk et al., Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation, Epidemiol Infect, vol.142, pp.1661-1670, 2014.

B. Evengard, K. Petersson, M. L. Engman, S. Wiklund, S. A. Ivarsson et al., Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden, Epidemiol Infect, vol.127, pp.121-127, 2001.

P. R. Torgerson and P. Mastroiacovo, The global burden of congenital toxoplasmosis: a systematic review, Bull World Health Organ, vol.91, pp.501-508, 2013.

F. Robert-gangneux and M. L. Darde, Epidemiology of and diagnostic strategies for toxoplasmosis, Clin Microbiol Rev, vol.25, pp.264-296, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00696903

P. A. Jenum, B. Stray-pedersen, K. K. Melby, G. Kapperud, A. Whitelaw et al., Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women, J Clin Microbiol, vol.36, pp.2900-2906, 1998.

J. M. Carrera, M. Torrents, C. Mortera, V. Cusi, and A. Munoz, Routine prenatal ultrasound screening for fetal abnormalities: 22 years' experience, Ultrasound Obstet Gynecol, vol.5, pp.174-179, 1995.

L. S. Chitty, G. H. Hunt, J. Moore, and M. O. Lobb, Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population, BMJ, vol.303, pp.1165-1169, 1991.

B. Ewigman, M. Lefevre, and J. Hesser, A randomized trial of routine prenatal ultrasound, Obstet Gynecol, vol.76, pp.189-194, 1990.

H. Grandjean, D. Larroque, and S. Levi, The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study, Am J Obstet Gynecol, vol.181, issue.99, pp.70577-70583, 1999.

S. Levi, Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for second trimester fetal malformations, Prenat Diagn, vol.22, pp.285-295, 2002.

J. K. Morris, A. L. Springett, R. Greenlees, M. Loane, M. C. Addor et al., Trends in congenital anomalies in Europe from 1980 to 2012, PLoS One, vol.13, 2018.

N. Andersen, A. M. Wohlfahrt, J. Christens, P. Olsen, J. Melbye et al., Maternal age and fetal loss: population based register linkage study, BMJ, vol.320, pp.1708-1712, 2000.

A. Delabaere, C. Huchon, X. Deffieux, G. Beucher, V. Gallot et al., , 2014.

, J Gynecol Obstet Biol Reprod, vol.43, pp.764-775

H. Pilkington, B. Blondel, N. Drewniak, and J. Zeitlin, Where does distance matter? Distance to the closest maternity unit and risk of foetal and neonatal mortality in France, Eur J Public Health, vol.24, pp.905-910, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02093164

J. G. Montoya and J. S. Remington, Management of Toxoplasma gondii infection during pregnancy, Clin Infect Dis, vol.47, pp.554-566, 2008.

D. Dunn, M. Wallon, F. Peyron, E. Petersen, C. Peckham et al., Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling, Lancet, vol.353, pp.1829-1833, 1999.

H. Autorité-de-santé, Surveillance sérologique et prévention de la toxoplasmose et de la rubé ole au cours de la grossesse et dé pistage prénatal de l'hépatite B-Pertinence des modalités de réalisation, 2009.

B. G. Ewigman, J. P. Crane, F. D. Frigoletto, L. Fevre, M. L. Bain et al., Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group, N Engl J Med, vol.329, pp.821-827, 1993.

V. Brocks and J. Bang, Routine examination by ultrasound for the detection of fetal malformations in a low risk population, Fetal Diagn Ther, vol.6, pp.37-45, 1991.

L. F. Goncalves, P. Jeanty, and J. M. Piper, The accuracy of prenatal ultrasonography in detecting congenital anomalies, Am J Obstet Gynecol, vol.171, pp.90411-90412, 1994.

M. Wallon, J. Franck, P. Thulliez, C. Huissoud, F. Peyron et al., Accuracy of realtime polymerase chain reaction for Toxoplasma gondii in amniotic fluid, Obstet Gynecol, vol.115, pp.727-733, 2010.

C. T. De-oliveira-azevedo, P. E. Do-brasil, L. Guida, L. Moreira, and M. E. , Performance of Polymerase Chain Reaction Analysis of the Amniotic Fluid of Pregnant Women for Diagnosis of Congenital Toxoplasmosis: A Systematic Review and Meta-Analysis, PLoS One, vol.11, 2016.

M. Lebech, O. Andersen, N. C. Christensen, J. Hertel, and H. E. Nielsen, Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group, Lancet, vol.353, pp.1834-1837, 1999.

A. Naessens, P. A. Jenum, A. Pollak, A. Decoster, M. Lappalainen et al., Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation, J Pediatr, vol.135, p.10586174, 1999.

Y. Naot, G. Desmonts, and J. S. Remington, IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection, J Pediatr, vol.98, pp.80528-80536, 1981.

F. Robert-gangneux, M. F. Gavinet, T. Ancelle, J. Raymond, C. Tourte-schaefer et al., Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases, J Clin Microbiol, vol.37, pp.2893-2898, 1999.

I. M. Rodrigues, A. M. Castro, M. B. Gomes, W. N. Amaral, and M. M. Avelino, Congenital toxoplasmosis: evaluation of serological methods for the detection of anti-Toxoplasma gondii IgM and IgA antibodies, Mem Inst Oswaldo Cruz, vol.104, pp.434-440, 2009.

M. Paul, Serological Screening of Newborns for Toxoplasma Gondii-Specific IgA and IgM Antibodies in Peripheral Blood Collected on Filter-Papers, EJIFCC, vol.18, pp.91-114, 2007.

C. Cornu, A. Bissery, C. Malbos, R. Garwig, C. Cocherel et al., Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France, Euro Surveill, vol.14, pp.21-25, 2009.

M. Wallon, C. Liou, P. Garner, and F. Peyron, Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy, BMJ, vol.318, pp.1511-1514, 1999.

G. Chene and R. Thiebaut, Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis, Mem Inst Oswaldo Cruz, vol.104, p.19430657, 2009.

R. E. Holliman, Congenital toxoplasmosis: prevention, screening and treatment, J Hosp Infect, vol.30, pp.179-190, 1995.

F. Derouin, L. Gerard, R. Farinotti, C. Maslo, and C. Leport, Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis, J Acquir Immune Defic Syndr Hum Retrovirol, vol.19, pp.50-54, 1998.

F. Derouin, J. Nalpas, and C. Chastang, In vitro measurement of the inhibitory effect of macrolides, lincosamides and synergestines on the growth of Toxoplasma gondii, 1988.

, Pathol Biol (Paris), vol.36, pp.1204-1210

W. Foulon, I. Villena, B. Stray-pedersen, A. Decoster, M. Lappalainen et al., Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year, Am J Obstet Gynecol, vol.180, pp.70224-70227, 1999.

E. Marseille, B. Larson, D. S. Kazi, J. G. Kahn, and S. Rosen, Thresholds for the cost-effectiveness of interventions: alternative approaches, Bull World Health Organ, vol.93, pp.118-124, 2015.

E. Stillwaggon, C. S. Carrier, M. Sautter, and R. Mcleod, Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model, PLoS Negl Trop Dis, vol.5, p.1333, 2011.

A. R. Prusa, D. C. Kasper, L. Sawers, E. Walter, M. Hayde et al., Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving, PLoS Negl Trop Dis, vol.11, 2017.

E. Bissati, K. Levigne, P. Lykins, J. Adlaoui, E. B. Barkat et al., Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis, Emerg Microbes Infect, vol.7, p.30262847, 2018.

D. Girard, A. Leclercq, E. Laurent, M. Lecuit, H. De-valk et al., Pregnancy-related listeriosis in France, Euro Surveill, 1984.
URL : https://hal.archives-ouvertes.fr/pasteur-02391783

A. S. Brown, C. A. Schaefer, C. P. Quesenberry, L. Liu, V. P. Babulas et al., Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring, Am J Psychiatry, vol.162, pp.767-773, 2005.

C. M. Bianchi, J. F. Huneau, L. Goff, G. Verger, E. O. Mariotti et al., Concerns, attitudes, beliefs and information seeking practices with respect to nutrition-related issues: a qualitative study in French pregnant women, BMC Pregnancy Childbirth, vol.16, p.27729021, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01488444

I. J. Begeman, J. Lykins, Y. Zhou, B. S. Lai, P. Levigne et al., Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries, PLoS Negl Trop Dis, vol.11, 2017.

J. Lykins, X. Li, P. Levigne, Y. Zhou, E. Bissati et al., Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies, PLoS Negl Trop Dis, vol.12, p.30114251, 2018.

E. Chapey, V. Meroni, F. Kieffer, L. Bollani, R. Ecochard et al., Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis, Clin Vaccine Immunol, vol.22, pp.398-403, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02044966